Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins

被引:258
作者
Wang, Guoping
Nikolovska-Coleska, Zaneta
Yang, Chao-Yie
Wang, Renxiao
Tang, Guozhi
Guo, Jie
Shangary, Sanjeev
Qiu, Su
Gao, Wei
Yang, Dajun
Meagher, Jennifer
Stuckey, Jeanne
Krajewski, Krzysztof
Jiang, Sheng
Roller, Peter P.
Abaan, Hatice Ozel
Tomita, York
Wang, Shaomeng
机构
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pharmacol & Med Chem, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA
[5] NCI, Lab Med Chem, NIH, Frederick, MD 21702 USA
[6] Georgetown Univ, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC 20057 USA
关键词
D O I
10.1021/jm060460o
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A structure-based approach was employed to design a new class of small-molecule inhibitors of Bcl-2. The most potent compound 5 (TW-37) binds to Bcl-2 with a K-i value of 290 nM and also to BclxL and Mcl-1 with high affinities. Compound 5 potently inhibits cell growth in PC-3 prostate cancer cells with an IC50 value of 200 nM and effectively induces apoptosis in a dose-dependent manner.
引用
收藏
页码:6139 / 6142
页数:4
相关论文
共 16 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]   BCL-2 FAMILY: Regulators of cell death [J].
Chao, DT ;
Korsmeyer, SJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :395-419
[3]   Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL [J].
Degterev, A ;
Lugovskoy, A ;
Cardone, M ;
Mulley, B ;
Wagner, G ;
Mitchison, T ;
Yuan, JY .
NATURE CELL BIOLOGY, 2001, 3 (02) :173-182
[4]   Discovery of small-molecule inhibitors of bcl-2 through structure-based computer screening [J].
Enyedy, IJ ;
Ling, Y ;
Nacro, K ;
Tomita, Y ;
Wu, XH ;
Cao, YY ;
Guo, RB ;
Li, BH ;
Zhu, XF ;
Huang, Y ;
Long, YQ ;
Roller, PP ;
Yang, DJ ;
Wang, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (25) :4313-4324
[5]   Discovery, characterization, and structure - Activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins [J].
Kitada, S ;
Leone, M ;
Sareth, S ;
Zhai, DY ;
Reed, JC ;
Pellecchia, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (20) :4259-4264
[6]   Recent progress on the regulation of apoptosis by Bcl-2 family members [J].
Minn, AJ ;
Swain, RE ;
Ma, A ;
Thompson, CB .
ADVANCES IN IMMUNOLOGY, VOL 70, 1998, 70 :245-279
[7]   An inhibitor of Bcl-2 family proteins induces regression of solid tumours [J].
Oltersdorf, T ;
Elmore, SW ;
Shoemaker, AR ;
Armstrong, RC ;
Augeri, DJ ;
Belli, BA ;
Bruncko, M ;
Deckwerth, TL ;
Dinges, J ;
Hajduk, PJ ;
Joseph, MK ;
Kitada, S ;
Korsmeyer, SJ ;
Kunzer, AR ;
Letai, A ;
Li, C ;
Mitten, MJ ;
Nettesheim, DG ;
Ng, S ;
Nimmer, PM ;
O'Connor, JM ;
Oleksijew, A ;
Petros, AM ;
Reed, JC ;
Shen, W ;
Tahir, SK ;
Thompson, CB ;
Tomaselli, KJ ;
Wang, BL ;
Wendt, MD ;
Zhang, HC ;
Fesik, SW ;
Rosenberg, SH .
NATURE, 2005, 435 (7042) :677-681
[8]   Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis [J].
Petros, AM ;
Dinges, J ;
Augeri, DJ ;
Baumeister, SA ;
Betebenner, DA ;
Bures, MG ;
Elmore, SW ;
Hajduk, PJ ;
Joseph, MK ;
Landis, SK ;
Nettesheim, DG ;
Rosenberg, SH ;
Shen, W ;
Thomas, S ;
Wang, XL ;
Zanze, I ;
Zhang, HC ;
Fesik, SW .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) :656-663
[9]   Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies [J].
Petros, AM ;
Nettesheim, DG ;
Wang, Y ;
Olejniczak, ET ;
Meadows, RP ;
Mack, J ;
Swift, K ;
Matayoshi, ED ;
Zhang, HC ;
Thompson, CB ;
Fesik, SW .
PROTEIN SCIENCE, 2000, 9 (12) :2528-2534
[10]   Solution structure of the antiapoptotic protein bcl-2 [J].
Petros, AM ;
Medek, A ;
Nettesheim, DG ;
Kim, DH ;
Yoon, HS ;
Swift, K ;
Matayoshi, ED ;
Oltersdorf, T ;
Fesik, SW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3012-3017